Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GNC personnel

This article was originally published in The Tan Sheet

Executive Summary

Royal Numico division announces promotion of J.J. Sorrenti to newly created post of senior VP-retail stores effective Jan. 3. Sorrenti, who will report to President & CEO Michael Meyers, "will oversee operations of all of GNC's U.S. retail stores," firm says. Sorrenti joined GNC in 1990 and has helped develop its franchise business and support system. Numico recently put GNC on "probation" to increase its sales and could divest the retail chain if the efforts are unsuccessful (1"The Tan Sheet" Nov. 11, 2002, p. 3)...

You may also be interested in...



GNC On The Line: Retailer Faces “Probation” Period To Shape Up Financials

Royal Numico is giving subsidiary GNC a 12- to 18-month probationary period to ramp up its financial performance, President & CEO Jan Bennink told analysts in London Nov. 8

Amgen/AstraZeneca’s Tezepelumab Cuts Asthma Exacerbations By 56%

Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics. 

Sarepta’s Next-Generation Drugs Draw Attention Amid ‘Incremental’ Approval

The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.

Topics

UsernamePublicRestriction

Register

OM007836

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel